The strategies of biotechnology companies that face similar uncertainties and illustrates different types of strategic responses to uncertainty. Each firm faces strategic issues that end-use industries choose as a broad line of products, there should be how to choose alliances, partnerships and licenses, to have enough money without giving up their profit potential, and how far the vertical integration. "Hide
by Elizabeth Olmsted Teisberg, Sharon Rossi Source: Harvard Business School 17 pages. Publication Date: April 16, 1992. Prod. #: 792082-PDF-ENG